Robert Hershberg Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity
Robert Hershberg is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 51,716 shares of RXRX, which is worth approximately $294,781. The most recent transaction as insider was on Jun 03, 2024, when has been sold 13,097 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
51.7K
0%
3M change
33.91%
12M change
Total Value Held
$294,781
ROBERT HERSHBERG Transaction History
Also insider at
RH
Robert Hershberg
Director
San Diego, CA